ITP
Iron Triangle Partners Portfolio holdings
AUM
$632M
This Quarter Return
+13.38%
1 Year Return
+26.53%
3 Year Return
+134.07%
5 Year Return
+312.1%
10 Year Return
–
AUM
$966M
AUM Growth
+$966M
(+25%)
Cap. Flow
+$131M
Cap. Flow
% of AUM
13.53%
Top 10 Holdings %
Top 10 Hldgs %
53.71%
Holding
39
New
13
Increased
10
Reduced
5
Closed
11
Top Buys
| 1 |
Exact Sciences
EXAS
|
$48.3M |
| 2 |
West Pharmaceutical
WST
|
$47.4M |
| 3 |
Align Technology
ALGN
|
$46.6M |
| 4 |
Apellis Pharmaceuticals
APLS
|
$32.3M |
| 5 |
Fortrea Holdings
FTRE
|
$31.8M |
Top Sells
| 1 |
Universal Health Services
UHS
|
$49.1M |
| 2 |
Idexx Laboratories
IDXX
|
$42.2M |
| 3 |
Surgery Partners
SGRY
|
$33.4M |
| 4 |
Inspire Medical Systems
INSP
|
$30.5M |
| 5 |
Elanco Animal Health
ELAN
|
$27.7M |
Sector Composition
| 1 | Healthcare | 97.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
argenx
ARGX
$44.2B
| $17.7M | 1.81% |
+45,000
| New | +$17.7M |
|
27
908 Devices
MASS
$214M
| $7.86M | 0.8% |
1,040,768
-244,179
| -19% | -$1.84M |
|
|
NYXH
28
Nyxoah
NYXH
$221M
| $3.41M | 0.35% |
+253,025
| New | +$3.41M |
|
29
10x Genomics
TXG
$1.66B
| – | – |
-479,374
| Closed | -$26.8M |
|
|
30
Universal Health Services
UHS
$11.6B
| – | – |
-321,886
| Closed | -$49.1M |
|
31
BioMarin Pharmaceuticals
BMRN
$11.3B
| – | – |
-200,000
| Closed | -$19.3M |
|
32
Establishment Labs
ESTA
$1.11B
| – | – |
-331,238
| Closed | -$8.58M |
|
|
33
Idexx Laboratories
IDXX
$50.7B
| – | – |
-76,025
| Closed | -$42.2M |
|
|
34
Inspire Medical Systems
INSP
$2.53B
| – | – |
-150,000
| Closed | -$30.5M |
|
35
Legend Biotech
LEGN
$6.64B
| – | – |
-380,000
| Closed | -$22.9M |
|
36
Pacific Biosciences
PACB
$378M
| – | – |
-1,843,278
| Closed | -$18.1M |
|
37
Repligen
RGEN
$6.54B
| – | – |
-82,537
| Closed | -$14.8M |
|
|
38
Surgery Partners
SGRY
$2.89B
| – | – |
-1,044,530
| Closed | -$33.4M |
|
39
Sanofi
SNY
$122B
| – | – |
-500,000
| Closed | -$24.9M |
|